Clinical Trials Logo

Carcinoma, Ductal, Breast clinical trials

View clinical trials related to Carcinoma, Ductal, Breast.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT05327608 Suspended - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery

Start date: July 28, 2022
Phase: N/A
Study type: Interventional

This trial studies whether intermittent fasting works to improve outcomes in patients with stage I-III breast cancer receiving chemotherapy before surgery (neoadjuvant) with a body mass index >= 25. Intermittent fasting has been shown to elicit similar metabolic changes as calorie restriction such as reduction in blood glucose levels, improved insulin sensitivity, and reduction of tumor cell growth. Intermittent fasting may improve outcomes in patients with breast cancer.